Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis RegistryÁsta Theódórsdóttir, Zsolt Illés, Peter Vestergaard Rasmussen et al.|Multiple Sclerosis Journal|2021Cited by 21
Natalizumab treatment of multiple sclerosis — a Danish nationwide study with 13 years of follow-upMathias Due Buron, Melinda Magyari, Jeppe Romme Christensen et al.|Multiple Sclerosis and Related Disorders|2023Cited by 6